Reassessing Veeva Systems (VEEV) Valuation Amid AI Sell-Off and Life Sciences Adoption

Veeva Systems (VEEV) has seen a 23.27% drop in its share price to $183.65 after a 7.6% decline tied to fears of artificial intelligence disruption. Despite this, new life sciences customers are adopting its cloud software platforms. The company's most followed narrative pegs fair value at $309.61, framing a significant valuation gap. The narrative is based on Veeva's cloud platform scaling across life sciences workflows and the resolution of a long-standing dispute with IQVIA.